MI Bioresearch Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MI Bioresearch Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014026
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous models, orthotopic models, metastasis models, disseminated models and PDX models. MI also offers services such as validation, candidate selection, optimization, modeling, PK/ PD profiling, biodistribution, custom models, consulting, and ex-vivo. The institute serves pharmaceutical, diagnostics, and medical device sectors. Molecular Imaging is headquartered in Ann Arbor, Michigan, the US.

MI Bioresearch Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MI Bioresearch Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MI Bioresearch Inc, Medical Devices Deals, 2011 to YTD 2017 9
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Molecular Imaging Raises USD1.5 Million in Venture Financing 11
Molecular Imaging Raises US$3.5 Million In Venture Financing 12
Molecular Imaging Research Raises Additional US$2.85 Million In Series A Financing 13
Molecular Imaging Raises US$7 Million In Venture Financing 14
Licensing Agreements 15
Molecular Imaging Enters Into Licensing Agreement With Dana-Farber Cancer Institute 15
MI Bioresearch Inc – Key Competitors 16
MI Bioresearch Inc – Key Employees 17
MI Bioresearch Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Other Significant Developments 19
Apr 07, 2016: Molecular Imaging Launches New Name; Presents Posters at the American Association of Cancer Research Annual Meeting 2016 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Key Facts 2
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MI Bioresearch Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MI Bioresearch Inc, Deals By Therapy Area, 2011 to YTD 2017 8
MI Bioresearch Inc, Medical Devices Deals, 2011 to YTD 2017 9
MI Bioresearch Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Molecular Imaging Raises USD1.5 Million in Venture Financing 11
Molecular Imaging Raises US$3.5 Million In Venture Financing 12
Molecular Imaging Research Raises Additional US$2.85 Million In Series A Financing 13
Molecular Imaging Raises US$7 Million In Venture Financing 14
Molecular Imaging Enters Into Licensing Agreement With Dana-Farber Cancer Institute 15
MI Bioresearch Inc, Key Competitors 16
MI Bioresearch Inc, Key Employees 17

★海外企業調査レポート[MI Bioresearch Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TransAlta Corporation:企業の戦略・SWOT・財務情報
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Heliatek GmbH:電力:M&Aディール及び事業提携情報
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Occidental Chemical Corp:企業の戦略的SWOT分析
    Occidental Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • TransAlta Corporation:企業の戦略・SWOT・財務分析
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ManpowerGroup Inc (MAN):企業の財務・戦略的SWOT分析
    ManpowerGroup Inc (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • University Health Network:製薬・医療:M&Aディール及び事業提携情報
    Summary University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibi …
  • Kerry Group plc:戦略・SWOT・企業財務分析
    Kerry Group plc - Strategy, SWOT and Corporate Finance Report Summary Kerry Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Econet Wireless Zimbabwe Ltd:企業の戦略・SWOT・財務分析
    Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Shopper’s Stop Ltd.:戦略・SWOT・企業財務分析
    Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Compagnie Plastic Omnium SA (POM):企業の財務・戦略的SWOT分析
    Compagnie Plastic Omnium SA (POM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kkr Financial Holdings Llc
    Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report Summary Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • China National Nuclear Power Co Ltd (601985):電力:M&Aディール及び事業提携情報
    Summary China National Nuclear Power Co Ltd (CNNPC), a subsidiary of China National Nuclear Corp is a nuclear energy company. The company provides activities such as development, investment, construction, operations and management of nuclear power projects and technical research in the safe operatio …
  • Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental c …
  • Miragen Therapeutics Inc (MGEN):医療機器:M&Aディール及び事業提携情報
    Summary Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), …
  • J.E. Dunn Construction Group, Inc.:企業の戦略的SWOT分析
    J.E. Dunn Construction Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) operates as a clinical-stage biopharmaceutical company. It carries out research, develop and commercialize gene editing technology. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target a …
  • Monsanto Company:企業の戦略・SWOT・財務情報
    Monsanto Company - Strategy, SWOT and Corporate Finance Report Summary Monsanto Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆